Amneal Pharmaceuticals (AMRX) Gross Profit Growth (1y) (2018 - 2026)
Amneal Pharmaceuticals (AMRX) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | 14.77% |
| 10 | Amneal Pharmaceuticals | 5.71 Bn | 5.71 Bn | 320.11 Mn | 25.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.10% |
| Dec 31, 2025 | 13.05% |
| Sep 30, 2025 | 1.64% |
| Jun 30, 2025 | 14.53% |
| Mar 31, 2025 | 7.49% |
| Dec 31, 2024 | 38.48% |
| Sep 30, 2024 | 15.92% |
| Jun 30, 2024 | 13.60% |
| Mar 31, 2024 | 33.60% |
| Dec 31, 2023 | -11.87% |
| Sep 30, 2023 | 19.72% |
| Jun 30, 2023 | 9.73% |
| Mar 31, 2023 | 2.07% |
| Dec 31, 2022 | 29.44% |
| Sep 30, 2022 | -2.16% |
| Jun 30, 2022 | -5.64% |
| Mar 31, 2022 | -8.87% |
| Dec 31, 2021 | -0.40% |
| Sep 30, 2021 | 48.60% |
| Jun 30, 2021 | 47.33% |